Abstract
Neuroimaging shed light on the understanding of psychopathological mechanisms underlying major depressive disorder, despite its inconsistent findings. Noninvasive neuroimaging studies have indicated that various behavioral deficits in major depressive disorder are implicated with structural and functional abnormalities in specific brain regions. Moreover, disrupted brain morphological and functional properties may map out the underlying pathways from genetic and environmental factors to the prognosis of depression. Molecular neuroimaging studies have also provided novel method to probe transmitters and metabolites in brain regions rather than simply measuring brain morphological changes. Recent advanced neuroimaging approaches (e.g., pattern recognition) provides great opportunity to probe neuroimaging biomarkers that may contributes to improving diagnostic accuracy and predicting treatment outcomes. In this chapter, we conclude neuroimaging studies in the research field of depression from psychopathological, molecular, genetic/environmental, diagnostic, and therapeutic perspectives.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alexander AL et al (2007) Diffusion tensor imaging of the brain 4(3):316–329
Alexopoulos GS et al (2012) Functional connectivity in the cognitive control network and the default mode network in late-life depression. 139(1):56
Almeida JR et al (2013) Pattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity. Br J Psychiatry 203(3):310–311
Amen DG et al (2017) Classification of depression, cognitive disorders, and co-morbid depression and cognitive disorders with perfusion SPECT neuroimaging 57(1):253–266
Ando T, Dunn AJ (1999) Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. NeuroImmunoModulation 6(5):319
Andrei M et al (2013) Insular dysfunction within the salience network is associated with severity of symptoms and aberrant inter-network connectivity in major depressive disorder 7(2):930
Arnone D (2019) Functional MRI findings, pharmacological treatment in major depression and clinical response. Prog Neuropsychopharmacol Biol Psychiatry 91:28–37
Ball TM, Stein MB, Paulus MP (2014) Toward the application of functional neuroimaging to individualized treatment for anxiety and depression. Depress Anxiety 31(11):920–933
Beijers L et al (2019) Data-driven biological subtypes of depression: systematic review of biological approaches to depression subtyping. Mol Psychiatry 24:888–900
Bick J et al (2019) Early parenting intervention and adverse family environments affect neural function in middle childhood. Biol Psychiatry 85(4):326–335
Breitenstein B, Scheuer S, Holsboer F (2014) Are there meaningful biomarkers of treatment response for depression? Drug Discov Today 19(5):539–561
Bunge SA, Kahn IJEoN (2009) Cognition: an overview of neuroimaging techniques 1063–1067
Carballedo A et al (2013) Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. Am J Med Genet B Neuropsychiatr Genet 162B(2):183–190
Cardoner N et al (2013) Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome. Depress Anxiety 30(3):225–233
Catenadell’Osso M et al (2013) Inflammation, serotonin and major depression. Curr Drug Targets 14(5):571–577
Chen J et al (2012) Genotypic association of the DAOA gene with resting-state brain activity in major depression. Mol Neurobiol 46(2):361–373
Chen Y et al (2015) Aberrant connectivity within the default mode network in first-episode, treatment-naïve major depressive disorder 183:49–56
Chen G et al (2017) Intrinsic disruption of white matter microarchitecture in first-episode, drug-naive major depressive disorder: a voxel-based meta-analysis of diffusion tensor imaging. Prog Neuropsychopharmacol Biol Psychiatry 76:179–187
Chi KF, Korgaonkar M, Grieve SM (2015) Imaging predictors of remission to anti-depressant medications in major depressive disorder. J Affect Disord 186:134–144
Christmas DM, Potokar J, Davies SJ (2011) A biological pathway linking inflammation and depression: activation of indoleamine 2, 3-dioxygenase. Neuropsychiatric Dis Treat 7:431
Costafreda SG et al (2009a) Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport 20(7):637–641
Costafreda SG et al (2009b) Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS ONE 4(7):e6353
Dantzer R, Capuron L (2017) Inflammation-associated depression: evidence, mechanisms and implications. Springer International Publishing
Dantzer R et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46
Delany FM et al (2016) Depression, immune function, and early adrenarche in children. Psychoneuroendocrinology 63:228–234
Deng F et al (2017) Abnormal segments of right uncinate fasciculus and left anterior thalamic radiation in major and bipolar depression. Prog Neuro-Psychopharmacol & Biol Psychiatry 81
Dichter GS, Gibbs D, Smoski MJ (2015) A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. J Affect Disord 172:8–17
Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095–2147
Domschke K et al (2016) Magnetoencephalographic correlates of emotional processing in major depression before and after pharmacological treatment. Int J Neuropsychopharmacol 19(2)
Drysdale AT et al (2017) Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 23(1):28–38
Dunlop BW et al (2017) Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am J Psychiatry 174(6):533–545
Dusi N et al (2015) Brain structural effects of antidepressant treatment in major depression. Curr Neuropharmacol 13(4):458–465
Eisenberger NI et al (2009) An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 47(3):881–890
Eisenberger NI et al (2010) Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiat 68(8):748–754
El-Hage W et al (2013) Mechanisms of antidepressant resistance. Front Pharmacol 4:146
Eschweiler GW et al (2000) Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Research: Neuroimaging 99(3):161–172
Felger JC et al (2016) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21(10):1358–1365
Feder S et al (2017) Sample heterogeneity in unipolar depression as assessed by functional connectivity analyses is dominated by general disease effects. J Affect Disord 222:79–87
Flint J, Kendler KS (2014) The genetics of major depression. Neuron 81(3):484–503
Frodl T, Amico F (2014) Is there an association between peripheral immune markers and structural/functional neuroimaging findings? Prog Neuropsychopharmacol Biol Psychiatry 48(2):295–303
Frodl T et al (2004) Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 65(4):492–499
Frodl TS et al (2008) Depression-related variation in brain morphology over 3 years: effects of stress? Arch Gen Psychiatry 65(10):1156–1165
Frodl T et al (2010) Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 35(6):1383–1390
Frodl T et al (2012) Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Translational Psychiatry 2(3):e88
Fu CH et al (2008) Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiat 64(6):505–512
Fujino J et al (2015) Anterior cingulate volume predicts response to cognitive behavioral therapy in major depressive disorder. J Affect Disord 174:397–399
Fung G et al (2015) Distinguishing bipolar and major depressive disorders by brain structural morphometry: a pilot study. Bmc Psychiatry 15(1):298
Gao S, Calhoun VD, Sui J (2018) Machine learning in major depression: from classification to treatment outcome prediction. CNS Neurosci Ther 24(11):1037–1052
Glover GH (2011) Overview of functional magnetic resonance imaging. Neurosurg Clin N Am 22(2):133–9, vii
Goldapple K et al (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61(1):34–41
Gong Q, He Y (2015) Depression, neuroimaging and connectomics: a selective overview. Biol Psychiatry 77(3):223–235
Gong L et al (2018) Disrupted reward and cognitive control networks contribute to anhedonia in depression. J Psychiatr Res 103:61–68
Guo H et al (2014) Synergistic effect of 5-HT2A receptor gene and MAOA gene on the negative emotion of patients with depression. Clin Physiol Funct Imaging 34(4):277–281
Han KM et al (2014) Cortical thickness, cortical and subcortical volume, and white matter integrity in patients with their first episode of major depression. J Affect Disord 155:42–48
Han KM et al (2017) Local gyrification index in patients with major depressive disorder and its association with tryptophan hydroxylase-2 (TPH2) polymorphism. Hum Brain Mapp 38(3):1299–1310
Hannestad J et al (2012) Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 63(1):232–239
Haroon E et al (2016) Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Molecular Psychiatry 21(10):1351–1357
Harrison NA et al (2011) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiat 66(5):407–414
Hayley S et al (2005) The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135(3):659–678
Hestad KA et al (2017) The relationships among tryptophan, kynurenine, indoleamine 2,3-dioxygenase, depression, and neuropsychological performance. Front Psychol 8(1561)
Himmerich H et al (2006) Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis. Biol Psychiat 60(8):882
Hirakawa N et al (2017) Right hemisphere pitch-mismatch negativity reduction in patients with major depression: An MEG study. J Affect Disord 215:225
Hosang GM et al (2014a) Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis 12(1):1–11
Hosang GM et al (2014b) Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 12:7
Hsieh MH et al (2002) Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry 17(6):519–525
Hsu DT et al (2012) Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing. J Neurosci 32(9):3253–3260
Huang TL, Lin CC (2015) Advances in biomarkers of major depressive disorder. Adv Clin Chem 68:177
Jaworska N et al (2016) The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study. BMC Psychiatry 16:61
Jefferson AL et al (2007) Inflammatory biomarkers are associated with total brain volume. The Framingham Heart Study 68(13):1032–1038
Jehn CF et al (2010) Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer. Integrative Cancer Therapies 9(3):270–275
Jiang J et al (2017) Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging. J Psychiatry Neurosci 42(3):150–163
Jie NF et al (2015) Discriminating bipolar disorder from major depression based on SVM-FoBa: efficient feature selection with multimodal brain imaging data. IEEE Trans Auton Ment Dev 7(4):320–331
Kambeitz J et al (2017) Detecting neuroimaging biomarkers for depression: a meta-analysis of multivariate pattern recognition studies. Biol Psychiatry 82(5):330–338
Kaneko N et al (2006) Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31(12):2619–2626
Kelly PA et al (2013) Cortical thickness, surface area, and gyrification abnormalities in children exposed to maltreatment: neural markers of vulnerability? Biol Psychiatry 74(11):845–852
Kennedy SH et al (2007) Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 164(5):778–788
Konarski JZ et al (2009) Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci 34(3):175–180
Korgaonkar MS et al (2014) Abnormal structural networks characterize major depressive disorder: a connectome analysis. Biol Psychiat 76(7):567–574
Kullmann JS et al (2013) Neural response to emotional stimuli during experimental human endotoxemia. Hum Brain Mapp 34(9):2217–2227
Lee BT et al (2009) Impact of the tryptophan hydroxylase 1 gene A218C polymorphism on amygdala activity in response to affective facial stimuli in patients with major depressive disorder. Genes Brain Behav 8(5):512–518
Lener MS, Iosifescu DV (2015) In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. Ann N Y Acad Sci 1344:50–65
Lener MS et al (2017) Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine. Biol Psychiatry 81(10):886–897
Leuchter AF et al (2010) Biomarkers to predict antidepressant response. Curr Psychiatry Rep 12(6):553–562
Li M et al (2013a) SLC6A15 rs1545843 and depression: implications from brain imaging data. Am J Psychiatry 170(7):805
Li B et al (2013b) A treatment-resistant default mode subnetwork in major depression. Biol Psychiat 74(1):48–54
Librenza-Garcia D et al (2017) The impact of machine learning techniques in the study of bipolar disorder: a systematic review. Neurosci Biobehav Rev 80:538–554
Linden DE (2012) The challenges and promise of neuroimaging in psychiatry. Neuron 73(1):8–22
Liu CH et al (2015a) Alteration of spontaneous neuronal activity within the salience network in partially remitted depression. Brain Res 1599:93–102
Liu CH et al (2015b) Alteration of spontaneous neuronal activity within the salience network in partially remitted depression. 1599:93
Liu Y, Zhao J, Guo W (2018) Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders. Front Psychol 9:2201
Lois G, Wessa M (2016) Differential association of default mode network connectivity and rumination in healthy individuals and remitted MDD patients. Soc Cogn Affect Neurosci 11(11):1792–1801
Lu Q et al (2013) Predicting depression based on dynamic regional connectivity: a windowed Granger causality analysis of MEG recordings. Brain Res 1535:52–60
Luborzewski A et al (2007) Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res 41(7):606–615
Macqueen G, Frodl T (2011) The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research|[quest]. Molecular Psychiatry 16(3):252
MacQueen GM et al (2008) Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry 64(10):880–883
Maglanoc LA et al (2019) Data-driven clustering reveals a link between symptoms and functional brain connectivity in depression. Biol Psychiatry Cogn Neurosci Neuroimaging 4(1):16–26
Marchand WR (2010) Cortico-basal ganglia circuitry: a review of key research and implications for functional connectivity studies of mood and anxiety disorders. Brain Struct Funct 215(2):73–96
Marsland AL et al (2008) Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiat 64(6):484
Masdeu JC (2011) Neuroimaging in psychiatric disorders. Neurotherapeutics 8(1):93–102
Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77(6):1690–1694
Mayer EA et al (2014) Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci Off J Soc Neuroscic 34(46):15490–15496
Mayer EA, Tillisch K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Investig 125(3):926–938
McGrath CL et al (2013) Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 70(8):821–829
Milak MS et al (2009) Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res 173(1):63–70
Miller JM et al (2013) Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry 74(10):760–767
Morón JA et al (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. Journal of Neuroscience the Official Journal of the Society for Neuroscience 23(24):8480
Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61(5):519–525
Myint A-M et al (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98(1–2):143–151
Nejad AB, Fossati P, Lemogne C (2013) Self-referential processing, rumination, and cortical midline structures in major depression. Front Hum Neurosci 7:666
Nugent AC et al (2016) Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder. Psychiatry Res Neuroimaging 254:56–66
Olbrich S, Arns MJIRoP (2013) EEG biomarkers in major depressive disorder: Discriminative power and prediction of treatment response 25(5):604–618
Opel N et al (2019) Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational study. The Lancet Psychiatry 6(4):318–326
Pemberton LA et al (1997) Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J Interf & Cytokine Res Off J Int Soc Interf & Cytokine Res 17(10):589–595
Peng D et al (2018) The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder. Front psychiatry 9:552
Pezawas L, Meyer-Lindenberg A (2010) Imaging genetics: Progressing by leaps and bounds. Neuroimage 53(3):801–803
Phillips ML et al (2003) Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiat 54(5):504–514
Phillips JL et al (2015a) Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression. Acta Neuropsychiatr 27(6):353–361
Phillips ML et al (2015b) Identifying Predictors. Moderators, and Mediators of Antidepressant Response in Major Depressive Disorder: Neuroimaging Approaches. 172(2):124–138
Phillips ML et al (2015c) Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. Am J Psychiatry 172(2):124–138
Pirnia T et al (2016) Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex. Transl Psychiatry 6(6):e832
Pizzagalli DA (2011) Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36(1):183–206
Price RB et al (2017a) Parsing heterogeneity in the brain connectivity of depressed and healthy adults during positive mood. Biol Psychiatry 81(4):347–357
Price RB et al (2017b) Data-driven subgroups in depression derived from directed functional connectivity paths at rest. Neuropsychopharmacology 42(13):2623–2632
Qin J et al (2017) Reconfiguration of hub-level community structure in depressions: a follow-up study via diffusion tensor imaging. J Affect Disord 207:305–312
Qiu M et al (2018) Aberrant neural activity in patients with bipolar depressive disorder distinguishing to the unipolar depressive disorder: a resting-state functional magnetic resonance imaging study. Front psychiatry 9:238
Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27(1):24–31
Rajeev K et al (2015) Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study. Neuroimage Clinical 9(3):e1
Redlich R et al (2014) Brain morphometric biomarkers distinguishing unipolar and bipolar depression. A voxel-based morphometry-pattern classification approach. JAMA Psychiatry 71(11): 1222–1230
Renteria ME et al (2017) Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working group. Transl Psychiatry 7(5):e1116
Richter-Levin G, Xu L (2018) How could stress lead to major depressive disorder? IBRO Rep 4:38–43
Ritchey M et al (2011) Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. J Psychiatr Res 45(5):577–587
Rosa MJ et al (2015) Sparse network-based models for patient classification using fMRI. Neuroimage 105:493–506
Rosa CE et al (2017) Glutamatergic and neural dysfunction in postpartum depression using magnetic resonance spectroscopy. Psychiatry Res 265:18–25
Sacchet MD et al (2015) Support vector machine classification of major depressive disorder using diffusion-weighted neuroimaging and graph theory. Front Psychiatry 6:21
Saleh A et al (2017) Effects of early life stress on depression, cognitive performance and brain morphology. Psychol Med 47(1):171–181
Sambataro F et al (2014) Revisiting default mode network function in major depression: evidence for disrupted subsystem connectivity. 44(10):2041
Satomura Y et al (2019) Severity-dependent and -independent brain regions of major depressive disorder: A long-term longitudinal near-infrared spectroscopy study. J Affect Disord 243:249–254
Savitz J et al (2013) Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav Immun 31(1):161
Schmaal L et al (2016) Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 21(6):806–812
Schmaal L et al (2017) Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry 22(6):900–909
Schoenfeld TJ et al (2017) Stress and loss of adult neurogenesis differentially reduce hippocampal volume. Biol Psychiatry 82(12):914–923
Setiawan E et al (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72(3):268–275
Sharpley CF, Agnew LL (2011) Cytokines and depression: findings, issues, and treatment implications. Rev Neurosci 22(3):295
Sheline YI et al (2010) Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A 107(24):11020–11025
Sheline YI et al (2012) Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry 169(11):1185–1193
Shelton RC et al (2009) Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 158(4):1406–1415
Shen T et al (2015) Increased cognition connectivity network in major depression disorder: a FMRI study. 12(2):227
Shirayama Y et al (2017) Myo-inositol, glutamate, and glutamine in the prefrontal cortex, hippocampus, and amygdala in major depression. Biol Psychiatry: Cogn Neurosci Neuroimaging 2(2):196–204
Siegle GJ, Carter CS, Thase ME (2006) Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 163(4):735–738
Siegle GJ et al (2012) Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch Gen Psychiatry 69(9):913–924
Singleton A, Hardy J (2011) A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. Hum Mol Genet 20(R2):R158–R162
Smitha DFJEN (2009) Molecular tools for assessing human depression by positron emission tomography 19(9):611–628
Straub J et al (2017) Successful group psychotherapy of depression in adolescents alters fronto-limbic resting-state connectivity. J Affect Disord 209:135–139
Su L et al (2014) Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. 14(1):1–7
Suh JS et al (2019) Cortical thickness in major depressive disorder: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 88:287–302
Symms M et al (2004) A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry 75(9):1235–1244
Takizawa R et al (2014) Neuroimaging-aided differential diagnosis of the depressive state. Neuroimage 85(1):498–507
Tang S et al (2018) Abnormal amygdala resting-state functional connectivity in adults and adolescents with major depressive disorder: a comparative meta-analysis. EBioMedicine 36:436–445
Taylor WD et al (2011) One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes. The American Journal of Geriatric Psychiatry 19(1):43–52
Taylor WD et al (2012) AGTR1 gene variation: association with depression and frontotemporal morphology. Psychiatry Res 202(2):104–109
Tekin S, Cummings JL (2002) Frontal–subcortical neuronal circuits and clinical neuropsychiatry: an update 53(2): 647–654
Tekin Erguzel T, Tas C, Cebi M (2015) A wrapper-based approach for feature selection and classification of major depressive disorder-bipolar disorders. Comput Biol Med 64:127–37
Tillisch K et al (2013) Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144(7):1394–1401
Tozzi L et al (2016) Single-nucleotide polymorphism of the FKBP5 gene and childhood maltreatment as predictors of structural changes in brain areas involved in emotional processing in depression. Neuropsychopharmacology 41(2):487–497
van der Schot AC et al (2009) Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch Gen Psychiatry 66(2):142–151
Viviani B et al (2003) Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the src family of kinases. J Neurosci 23(25):8692–8700
Wang Z et al (2012) Abnormal default-mode network in angiotensin converting enzyme D allele carriers with remitted geriatric depression. Behav Brain Res 230(2):325–332
Wang L et al (2014a) Overlapping and segregated resting-state functional connectivity in patients with major depressive disorder with and without childhood neglect. Hum Brain Mapp 35(4):1154–1166
Wang L et al (2014b) Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging. Psychol Med 44(7):1417–1426
Wegener I et al (2015) Changes of explicitly and implicitly measured self-esteem in the treatment of major depression: evidence for implicit self-esteem compensation. Compr Psychiatry 58:57–67
Widge AS et al (2018) Electroencephalographic biomarkers for treatment response prediction in major depressive illness: a meta-analysis. Am J Psychiatry 176(1):44–56
Wilkin TJ et al (2009) Regimen simplification to Atazanavir-Ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. J Infect Dis 199(6):866–871
Wise T et al (2016) Voxel-Based Meta-Analytical Evidence of Structural Disconnectivity in Major Depression and Bipolar Disorder. Biol Psychiatry 79(4):293–302
Wu HQ, Rassoulpour A, Schwarcz R (2007) Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? Journal of Neural Transmission 114(1):33–41
Wu MJ et al (2015) Prediction of pediatric unipolar depression using multiple neuromorphometric measurements: a pattern classification approach. J Psychiatr Res 62:84–91
Wohleb ES et al (2011) ß-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity. J Neurosci 31(17):6277–6288
Yang W et al (2016) Abnormal brain activation during directed forgetting of negative memory in depressed patients. J Affect Disord 190:880–888
Yang XH et al (2017a) Anhedonia correlates with abnormal functional connectivity of the superior temporal gyrus and the caudate nucleus in patients with first-episode drug-naive major depressive disorder. J Affect Disord 218:284–290
Yang XH et al (2017b) White matter microstructural abnormalities and their association with anticipatory anhedonia in depression. Psychiatry Res 264:29–34
Yeh YW et al (2014) Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM. Int J Neuropsychopharmacol 18(3)
Zalcman S et al (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643(1–2):40–49
Zeng LL et al (2012) Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis. 135(Pt 5):1498
Zhai ZW et al (2019) Childhood trauma moderates inhibitory control and anterior cingulate cortex activation during stress. Neuroimage 185:111–118
Zhang J et al (2011) Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder. Biol Psychiatry 70(4):334–342
Zhang X et al (2014) First-episode medication-naive major depressive disorder is associated with altered resting brain function in the affective network 9(1):e85241
Zhang K et al (2016a) Molecular, Functional, and Structural Imaging of Major Depressive Disorder. Neurosci Bull 32(3):273–285
Zhang X et al (2016b) Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study. J Affect Disord 201:153–161
Zhang FF et al (2018a) Brain structure alterations in depression: psychoradiological evidence. CNS Neurosci Ther 24(11):994–1003
Zhang H et al (2019) Intrinsic gray-matter connectivity of the brain in major depressive disorder. J Affect Disord 251:78–85
Zhang HF, Mellor D, Peng DH (2018b) Neuroimaging genomic studies in major depressive disorder: a systematic review. CNS Neurosci Ther 24(11):1020–1036
Zunszain PA, Hepgul N, Pariante CM (2012) Inflammation and depression. In: Behavioral neurobiology of depression and its treatment. Springer, pp 135–151
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Peng, D., Yao, Z. (2019). Neuroimaging Advance in Depressive Disorder. In: Fang, Y. (eds) Depressive Disorders: Mechanisms, Measurement and Management. Advances in Experimental Medicine and Biology, vol 1180. Springer, Singapore. https://doi.org/10.1007/978-981-32-9271-0_3
Download citation
DOI: https://doi.org/10.1007/978-981-32-9271-0_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9270-3
Online ISBN: 978-981-32-9271-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)